Mitera Biosciences Inc.

Bellevue, WA · Founded 2020 · CIK 0002022224 · Biotech · Private

Investigational immunosuppressive therapeutics targeting T cell and B cell pathways

miterabio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.7M
2 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$600,000
Private capital raisedForm D · SEC$1,100,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1905Hemispherian AS—$108K
1906MBF THERAPEUTICS, INC.—$2.0M
1907GRANNUS THERAPEUTICS, INC.—$1.8M
1908Mitera Biosciences Inc.—$1.7M
1909Regranion, LLC——
1910Yobee Care, Inc.—$1.4M
1911Wise Trading Technologies, Inc.—$85K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Kevin ChowDirector · Executive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.